Chin Kook Rhee Selected Research

zabofloxacin

1/2020	Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations.
1/2015	Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chin Kook Rhee Research Topics

Disease

90	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 08/2013
58	Asthma (Bronchial Asthma) 02/2024 - 01/2009
27	Inflammation (Inflammations) 03/2023 - 01/2009
15	Pneumonia (Pneumonitis) 01/2023 - 01/2009
12	Airway Remodeling 01/2021 - 01/2009
9	Respiratory Hypersensitivity 03/2021 - 03/2014
7	Chronic Bronchitis 02/2024 - 01/2016
7	Bronchiectasis 02/2024 - 01/2016
7	Neutropenia 12/2018 - 01/2009
6	Bronchiolitis Obliterans Syndrome 11/2023 - 01/2016
6	Emphysema 01/2022 - 07/2015
6	Tuberculosis (Tuberculoses) 10/2021 - 09/2012
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 12/2012
6	Neoplasms (Cancer) 01/2021 - 03/2013
6	Dyspnea (Shortness of Breath) 01/2020 - 01/2015
5	Cough 10/2021 - 01/2016
5	Hyperplasia 01/2021 - 01/2017
5	Infections 08/2020 - 09/2012
5	Acute Lung Injury 06/2017 - 11/2010
4	Lung Injury 06/2017 - 11/2010
4	Respiratory Insufficiency (Respiratory Failure) 08/2015 - 01/2009
3	Obesity 08/2023 - 11/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 03/2023 - 06/2018
3	Hypoxia (Hypoxemia) 01/2022 - 01/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 01/2016
3	Gastroesophageal Reflux (GERD) 10/2021 - 08/2013
3	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2016
3	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2020 - 05/2012
3	Respiratory Sounds (Crackle) 01/2020 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2013
3	Obstructive Lung Diseases (Obstructive Lung Disease) 12/2017 - 07/2015
3	Fibrosis (Cirrhosis) 05/2016 - 11/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2011 - 12/2009
2	Heart Failure 01/2024 - 01/2020
2	Rhinosinusitis 11/2023 - 05/2021
2	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2021
2	Idiopathic Pulmonary Fibrosis 11/2023 - 05/2017
2	Pulmonary Tuberculosis 04/2023 - 01/2020
2	Chronic Cough 10/2021 - 01/2016
2	somatic cough syndrome 10/2021 - 01/2016
2	Bronchiolitis 10/2021 - 01/2016
2	Obstructive Sleep Apnea 10/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

37	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 02/2013
18	Bronchodilator Agents (Bronchodilators)IBA 02/2024 - 07/2014
18	OvalbuminIBA 03/2023 - 01/2009
16	CytokinesIBA 03/2023 - 07/2012
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2015
12	GoldIBA 07/2023 - 09/2012
9	Oxygen (Dioxygen)IBA 05/2022 - 07/2015
8	InterleukinsIBA 01/2023 - 06/2013
8	SteroidsIBA 01/2023 - 01/2015
7	RoflumilastIBA 02/2024 - 05/2016
7	Tiotropium Bromide (Spiriva)FDA Link 11/2023 - 07/2012
7	CollagenIBA 01/2021 - 07/2012
6	Muscarinic AntagonistsIBA 02/2024 - 08/2013
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2013
5	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 05/2016
4	Methacholine Chloride (Methacholine)FDA Link 12/2022 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2013
4	Interleukin-33IBA 10/2021 - 01/2017
4	Pravastatin (Pravachol)FDA LinkGeneric 11/2019 - 11/2010
4	nilotinib FDA Link 11/2016 - 01/2011
3	Interleukin-5 (Interleukin 5)IBA 01/2024 - 01/2022
3	anti-IgE antibodiesIBA 12/2023 - 01/2021
3	Budesonide (Pulmicort)FDA LinkGeneric 11/2023 - 01/2016
3	Formoterol Fumarate (Oxis)FDA Link 11/2023 - 01/2016
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023 - 09/2020
3	Thymic Stromal LymphopoietinIBA 01/2023 - 05/2018
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2018
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2021 - 07/2012
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 01/2016
3	indacaterolIBA 04/2021 - 01/2017
3	C-Reactive ProteinIBA 01/2021 - 01/2018
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021 - 01/2018
3	25-hydroxyvitamin DIBA 01/2020 - 01/2015
3	LipopolysaccharidesIBA 06/2017 - 03/2013
3	AllergensIBA 06/2014 - 01/2009
3	Imatinib Mesylate (Gleevec)FDA Link 06/2013 - 01/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2011 - 12/2009
2	DesmosineIBA 05/2023 - 01/2018
2	prednylidene (Pred)IBA 04/2023 - 01/2023
2	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2023 - 07/2012
2	NF-kappa B (NF-kB)IBA 03/2023 - 03/2013
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2023 - 11/2016
2	insulin receptor-related receptor (IRR)IBA 01/2023 - 01/2020
2	dupilumabIBA 03/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 03/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2018
2	Proton Pump InhibitorsIBA 10/2021 - 01/2016
2	Carbon MonoxideIBA 05/2021 - 12/2020

Therapy/Procedure

33	Therapeutics 04/2024 - 01/2009
13	Nebulizers and Vaporizers (Inhaler) 01/2024 - 01/2016
6	Hematopoietic Stem Cell Transplantation 11/2023 - 01/2015
4	Biological Therapy 02/2024 - 01/2022
4	Aftercare (After-Treatment) 01/2020 - 01/2015
3	Artificial Respiration (Mechanical Ventilation) 05/2021 - 12/2018
3	Drug Therapy (Chemotherapy) 09/2020 - 12/2016
2	Dry Powder Inhalers 04/2024 - 01/2019
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 10/2014
2	Peritoneal Dialysis 10/2021 - 01/2016